Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Clinical study of xofigo radium 223 dichloride phase 1 2?Ezetimibe georgia price?Patent for the shingles vaccine?Prednisone drug costs?When does emgality go off paten?
See the DrugPatentWatch profile for nivolumab
Nivolumab is marketed by Bristol Myers Squibb (BMS) under the brand name Opdivo. [1]
Based on the information provided here, Opdivo (nivolumab) is associated with Bristol Myers Squibb. [1]
You can look up nivolumab on DrugPatentWatch.com, which tracks drug and patent information and typically links to the market authorization holder/company. [1] Sources [1] https://www.drugpatentwatch.com/
Other Questions About Nivolumab :